Harvard Bioscience Inc.

Chane Graziano, the CEO of Holliston-based Harvard Bioscience Inc., has resigned for personal reasons after 17 years in that role and will retire, the company's directors announced today.

A tracheal scaffold and bioreactor system manufactured by Holliston-based Harvard Bioscience were used in the first successful transplant of a regenerated trachea in the United States, the company announced.

Harvard Bioscience Inc., the Holliston maker of tools used in life science research, posted mixed results for its fourth quarter and fiscal year ending Dec. 31.

Harvard Bioscience Inc., the Holliston-based maker of tools used in life science research, reported a slight decline...

Holliston-based Harvard Bioscience Inc. (HBIO) said its revenues were up 5 percent in the second quarter, to $28.5...

Holliston-based Harvard Bioscience rolled out a bioreactor in 2010 that's now playing a vital role in the...

Harvard Bioscience Inc., a Holliston-based life sciences products manufacturer, said one of its products was used for...